Celgene (NASDAQ:CELG)

Biotechnology word cloud

Short Interest in Biotechs Signals Optimism

The short interest data are out for the December 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
462542665

Celgene Expects to More Than Triple Earnings by 2020

Celgene Corp. (NASDAQ: CELG) provided a preliminary look at its financials for 2014 but also gave its financial outlook for 2015 and far beyond at the Annual J.P. Morgan Healthcare ...
Read Full Story »
Biotechnology word cloud

Wells Fargo’s Top Biotech Stocks for 2015

Looking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo ...
Read Full Story »
buy sell

5 Massive Upside Stocks for 2015

24/7 Wall St. has evaluated many top outside stock picks for 2014 from Wall Street analysts and market pundits. With the Dow Jones Industrial Average and S&P hitting new all-time ...
Read Full Story »
research

RBC’s 5 Top Biotech Stocks to Buy for 2015

As the year 2014 heads toward the finish line, many of the top Wall Street firms are sharpening their pencils and getting top ideas that make good sense for 2015 out ...
Read Full Story »
health care

Merrill Lynch’s Top Health Care Stock Picks for 2015

Merrill Lynch released its report looking forward to 2015 and which stocks it believes will outperform in the health care sector. In 2014, many of these same companies had very ...
Read Full Story »
biotech

Are Investors Signaling Optimism in Biotechs Through Short Interest?

The short interest data are out for the November 28 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Cisco, DreamWorks, Lululemon, Nabors, Schlumberger, Verizon and More

Stocks were indicated much lower on Tuesday as the market is dealing with lower commodities (oil and more) and a weak China and Europe. What has been proven repeatedly in ...
Read Full Story »
DNA

Mixed Readings For Biotech Short Interest

The short interest data are out for the November 14 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
biotech

RBC Has Three Top Biotech Picks for Year End and 2015

If any sector has had an up and down 2014, it would be the biotech. A massive sell-off in the spring and in the fall has given some biotech investors ...
Read Full Story »
Biotechnology word cloud

Biotech Short Interest Becomes Stock Specific (Updated)

The short interest data are out for the October 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Wall Street

Top Stocks Sold as Insiders Take Advantage of Huge Market Rally

Needless to say, nothing like a good old-fashioned stock market rally to get the sellers out from the shadows. Just a few short weeks ago, the market was one bad ...
Read Full Story »
Biotechnology word cloud

Biotech Short Interest Becomes Stock Specific

The short interest data are out for the October 15, settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
DNA

Will Celgene Become the Next $100 Billion Biotech Stock?

Does Celgene Corporation (NASDAQ: CELG) have what it takes to make it to a $100 billion market cap? Some analysts would think so, following the favorable release of this biotech ...
Read Full Story »
Biotechnology word cloud

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

The recent market sell-off spared no sector, and the top biotechnology stocks were treated with their own trip to the woodshed. Rising trends in prescriptions and higher, yet beatable increases ...
Read Full Story »